Mizuho Trims GE HealthCare Technologies (NASDAQ:GEHC) Target Price to $105.00

GE HealthCare Technologies (NASDAQ:GEHC) had its price objective lowered by Mizuho from $110.00 to $105.00 in a research report report published on Wednesday, Benzinga reports. The brokerage currently has a buy rating on the stock.

A number of other research firms have also recently weighed in on GEHC. Evercore ISI raised their price target on GE HealthCare Technologies from $93.00 to $100.00 and gave the company an outperform rating in a report on Thursday, April 4th. Argus raised their price target on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a buy rating in a report on Monday, April 1st. Morgan Stanley raised their price target on GE HealthCare Technologies from $74.00 to $86.00 and gave the company an equal weight rating in a report on Monday, February 12th. HSBC started coverage on GE HealthCare Technologies in a report on Thursday, February 15th. They set a buy rating and a $100.00 price target for the company. Finally, UBS Group raised GE HealthCare Technologies from a sell rating to a neutral rating and lifted their target price for the company from $66.00 to $88.00 in a research note on Monday, February 12th. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of Moderate Buy and an average target price of $95.00.

GE HealthCare Technologies Trading Up 2.1 %

Shares of GEHC opened at $79.47 on Wednesday. GE HealthCare Technologies has a 1 year low of $62.35 and a 1 year high of $94.50. The company has a current ratio of 1.06, a quick ratio of 0.83 and a debt-to-equity ratio of 1.11. The stock has a 50 day simple moving average of $88.25 and a 200-day simple moving average of $78.89. The stock has a market cap of $36.27 billion, a PE ratio of 23.24, a PEG ratio of 2.80 and a beta of 1.26.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Tuesday, April 30th. The company reported $0.90 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.90. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The firm had revenue of $4.65 billion during the quarter, compared to analysts’ expectations of $4.80 billion. During the same period last year, the firm posted $0.85 EPS. The business’s revenue was down 1.2% on a year-over-year basis. On average, sell-side analysts predict that GE HealthCare Technologies will post 4.27 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be given a $0.03 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.15%. GE HealthCare Technologies’s dividend payout ratio is currently 3.51%.

Insider Transactions at GE HealthCare Technologies

In related news, insider Frank R. Jimenez purchased 1,315 shares of GE HealthCare Technologies stock in a transaction dated Wednesday, May 1st. The shares were acquired at an average cost of $76.52 per share, for a total transaction of $100,623.80. Following the transaction, the insider now directly owns 75,796 shares of the company’s stock, valued at $5,799,909.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 0.27% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Capital Research Global Investors lifted its holdings in GE HealthCare Technologies by 2.8% during the fourth quarter. Capital Research Global Investors now owns 51,344,719 shares of the company’s stock worth $3,969,975,000 after acquiring an additional 1,401,566 shares in the last quarter. Vanguard Group Inc. lifted its holdings in GE HealthCare Technologies by 14.7% during the third quarter. Vanguard Group Inc. now owns 44,531,402 shares of the company’s stock worth $3,029,917,000 after acquiring an additional 5,693,244 shares in the last quarter. Hotchkis & Wiley Capital Management LLC lifted its holdings in GE HealthCare Technologies by 9.4% during the fourth quarter. Hotchkis & Wiley Capital Management LLC now owns 5,511,973 shares of the company’s stock worth $426,186,000 after acquiring an additional 471,910 shares in the last quarter. Invesco Ltd. lifted its holdings in GE HealthCare Technologies by 21.4% during the third quarter. Invesco Ltd. now owns 5,048,262 shares of the company’s stock worth $343,484,000 after acquiring an additional 889,297 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its holdings in GE HealthCare Technologies by 7.8% during the third quarter. Bank of New York Mellon Corp now owns 4,380,408 shares of the company’s stock worth $298,043,000 after acquiring an additional 315,808 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.